Xencor Reports First Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as oil gains curb risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- Reddit to join S&P 500 index on Aug. 18, shares leap
Xencor (XNCR) Tops Q1 EPS by 63c, Revenues Beat
May 5, 2021 4:40 PM EDTXencor (NASDAQ: XNCR) reported Q1 EPS of ($0.04), $0.63 better than the analyst estimate of ($0.67). Revenue for the quarter came in at $33.97 million versus the consensus estimate of $16.45 million.
"We continue to expand and mature our clinical portfolio of XmAb® drug candidates, recently initiating a... More
